Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam P Dicker

Showing results (141-150 of 286) with videos related to

Pageof 29
Sort By:
JCO Oncology Practice|April 8, 2022
A Pilot Feasibility Study of Digital Health Coaching for Men With Prostate CancerNathan R Handley, Kuang-Yi Wen, Sameh Gomaa, et al.
Molecular Imaging|March 14, 2014
The antiangiogenic effects of a vascular endothelial growth factor decoy receptor can be monitored in vivo using contrast-enhanced ultrasound imagingFlemming Forsberg, Raymond J Ro, Andrew Marshall, et al.
The Oncologist|January 10, 2013
Nutrient restriction and radiation therapy for cancer treatment: when less is moreColin E Champ, Renato Baserga, Mark V Mishra, et al.
Cancer|December 20, 2011
Improving prognosis of glioblastoma in the 21st century: who has benefited most?Yaacov Richard Lawrence, Mark V Mishra, Maria Werner-Wasik, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 16, 2026
Patient Advocate-Trainee Engagement in Oncology Education: Insights from a Short Pilot SurveyChristina A Simone-Soule, Sara E Burke, Dema Abul-Enin, et al.
Nature Reviews. Urology|September 11, 2013
Evolution of advanced technologies in prostate cancer radiotherapyNicholas G Zaorsky, Amy S Harrison, Edouard J Trabulsi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Prostate-specific antigen doubling time as a surrogate marker for evaluation of oncologic drugs to treat prostate cancerGary J Kelloff, Donald S Coffey, Bruce A Chabner, et al.
Future Oncology (London, England)|December 14, 2011
Comparative effectiveness research for prostate cancer radiation therapy: current status and future directionsXinglei Shen, Nicholas G Zaorsky, Mark V Mishra, et al.
Plos One|April 4, 2015
Evaluating the clinical impact of a genomic classifier in prostate cancer using individualized decision analysisJennifer Mason Lobo, Adam P Dicker, Christine Buerki, et al.
Medrxiv : the Preprint Server for Health Sciences|August 6, 2025
Enhancing Radiation Oncology Training through Patient Advocate IntegrationChristina A Simone-Soule, Sara E Burke, Dema Abul-Enin, et al.
Pageof 29

Showing results (141-150 of 286) with videos related to

Sort By:
Pageof 29
JCO Oncology Practice|April 8, 2022
A Pilot Feasibility Study of Digital Health Coaching for Men With Prostate CancerNathan R Handley, Kuang-Yi Wen, Sameh Gomaa, et al.
Molecular Imaging|March 14, 2014
The antiangiogenic effects of a vascular endothelial growth factor decoy receptor can be monitored in vivo using contrast-enhanced ultrasound imagingFlemming Forsberg, Raymond J Ro, Andrew Marshall, et al.
The Oncologist|January 10, 2013
Nutrient restriction and radiation therapy for cancer treatment: when less is moreColin E Champ, Renato Baserga, Mark V Mishra, et al.
Cancer|December 20, 2011
Improving prognosis of glioblastoma in the 21st century: who has benefited most?Yaacov Richard Lawrence, Mark V Mishra, Maria Werner-Wasik, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 16, 2026
Patient Advocate-Trainee Engagement in Oncology Education: Insights from a Short Pilot SurveyChristina A Simone-Soule, Sara E Burke, Dema Abul-Enin, et al.
Nature Reviews. Urology|September 11, 2013
Evolution of advanced technologies in prostate cancer radiotherapyNicholas G Zaorsky, Amy S Harrison, Edouard J Trabulsi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Prostate-specific antigen doubling time as a surrogate marker for evaluation of oncologic drugs to treat prostate cancerGary J Kelloff, Donald S Coffey, Bruce A Chabner, et al.
Future Oncology (London, England)|December 14, 2011
Comparative effectiveness research for prostate cancer radiation therapy: current status and future directionsXinglei Shen, Nicholas G Zaorsky, Mark V Mishra, et al.
Plos One|April 4, 2015
Evaluating the clinical impact of a genomic classifier in prostate cancer using individualized decision analysisJennifer Mason Lobo, Adam P Dicker, Christine Buerki, et al.
Medrxiv : the Preprint Server for Health Sciences|August 6, 2025
Enhancing Radiation Oncology Training through Patient Advocate IntegrationChristina A Simone-Soule, Sara E Burke, Dema Abul-Enin, et al.
Pageof 29